Cargando…
Structures of Leishmania Fructose-1,6-Bisphosphatase Reveal Species-Specific Differences in the Mechanism of Allosteric Inhibition
The gluconeogenic enzyme fructose-1,6-bisphosphatase has been proposed as a potential drug target against Leishmania parasites that cause up to 20,000–30,000 deaths annually. A comparison of three crystal structures of Leishmania major fructose-1,6-bisphosphatase (LmFBPase) along with enzyme kinetic...
Autores principales: | Yuan, Meng, Vásquez-Valdivieso, Montserrat G., McNae, Iain W., Michels, Paul A.M., Fothergill-Gilmore, Linda A., Walkinshaw, Malcolm D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639204/ https://www.ncbi.nlm.nih.gov/pubmed/28882541 http://dx.doi.org/10.1016/j.jmb.2017.08.010 |
Ejemplares similares
-
Structures of pyruvate kinases display evolutionarily divergent allosteric strategies
por: Morgan, Hugh P., et al.
Publicado: (2014) -
Kinetic and structural studies of Trypanosoma and Leishmania phosphofructokinases show evolutionary divergence and identify AMP as a switch regulating glycolysis versus gluconeogenesis
por: Fernandes, Peter M., et al.
Publicado: (2020) -
An allostatic mechanism for M2 pyruvate kinase as an amino-acid sensor
por: Yuan, Meng, et al.
Publicado: (2018) -
Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches
por: Fernandes, Peter M., et al.
Publicado: (2020) -
Fructose 1,6-bisphosphatase: getting the message across
por: Timson, David J.
Publicado: (2019)